Means of increasing sensitivity of an in vitro diagnostic test for aspirin intolerance

Clinical and Experimental Allergy

Volumn 29, Issue 10, 1999, Pages 1402-1411

  May, A ^b   Weber, A ^b   Gall, H ^b   Kaufmann, R ^b   Zollner, T M ^a  

^a GOETHE UNIVERSITY MEDICAL SCHOOL   (Germany)

^b NONE

Author keywords

Aspirin; Asthma; Diclofenac; Indomethacin; Intolerance; Leucotriene; Nasal polyps; Non steroidal anti inflammatory drugs; Urticaria

Indexed keywords

ACETYLSALICYLIC ACID; BUDESONIDE; COMPLEMENT COMPONENT C5A; DICLOFENAC; GLUCOCORTICOID; IMMUNOGLOBULIN E; INDOMETACIN; LEUKOTRIENE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; ASTHMA; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC TEST; DRUG HYPERSENSITIVITY; DRUG SENSITIZATION; FEMALE; HUMAN; LEUKOCYTE; MALE; NOSE POLYP; PRIORITY JOURNAL; PROVOCATION TEST; SYMPTOMATOLOGY; URTICARIA;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; LEUKOCYTES; LEUKOTRIENE C4; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 0032860590     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1999.00655.x     Document Type: Article

References (37)

1. 1 Samter M, Beers RF. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Int Med 1968; 68:975-83.
2. 2 Settipane GA. Aspirin and allergic diseases: a review. Am J Med 1983; 74:102-9.
3. 3 Szczeklik A. Mechanism of aspirin-induced asthma. Allergy 1997; 52:613-9.
4. 4 Gall H, Sterry W. Gibt es eine Analgetika-Intoleranz? Dtsch Med Wschr 1994; 119:480-1.
5. 5 Robinson DR, Skoskiewicz M, Bloch KJ et al. Cyclooxygenase blockade elevates leukotriene E4 production during acute anaphylaxis in sheep. J Exp Med 1986; 163:1509-17.
6. 6 Szczeklik A, Gryglewski RJ, Czerniawaska-Mysik G. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J 1975; 1:67-9.
7. 7 Pinto S, Gallo O, Polli G et al. Cyclooxygenase and lipoxygenase metabolite generation in nasal polyps. Prostaglandins Leukot Essent Fatty Acids 1997; 57:533-7.
8. 8 Oosaki R, Mizushima Y, Mita H, Shida T, Akiyama K, Kobayashi M. Urinary leukotrienc E4 and 11-dehydrothromboxane B2 in patients with aspirin-sensitive asthma. Allergy 1997; 52:470-3.
9. 9 Kumlin M, Stensvad F, Larsson L, Dahlen B, Dahlen S-E. Validation and application of a new simple strategy for measurements of urinary leukotriene E4 in humans. Clin Exp Allergy 1995; 25:467-79.
10. 10 Mewes T, Riechelmann H, Klimek L. Increased in vitro cysteinyl leukotriene release from blood leukocytes in patients with asthma, nasal polyps, and aspirin intolerance. Allergy 1996; 51:506-10.
11. 11 De Weck AL, Stadler BM, Urwyler A, Wehner HU, Bühlmann RP. Cellular allergen stimulation test (CAST): a new dimension in allergy diagnostics. Allergy Clin Immunol News 1993; 5:9-14.
12. 12 Czech W, Schöpf E, Kapp A. Release of sulfidoleukotrienes in vitro: Its relevance in the diagnosis of pseudoallergy to acetylsalicylic acid. Inflamm Res 1995; 44:291-5.
13. 13 Juergens UR, Christiansen SC, Stevenson DD, Zuraw BL. Inhibition of monocyte leukotriene B4 production after aspirin desensitization. J Allergy Clin Irnmunol 1995; 96:148-56.
14. 14 Wedi B, Elsner J, Kapp A. In vitro diagnostic of pseudoallergic reactions - new aspects. Allergy Clin Immunol Int 1996; 8:113-5.
15. 15 Ameisen JC, Capron A, Joseph M et al. Aspirin-sensitive asthma: abnormal platelet response to drugs inducing asthma attacks. Diagnostic and physiopathological implications. Int Arch Allergy Appl Immunol 1985; 78:438-48.
16. 16 Wüthrich B. Acetylsalicylic acid pseudoallergy: an anomaly of thrombocyte function? Hautarzt 1988; 39:631-4.
17. 17 Cowburn AS, Sladek K, Soja J et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998; 101:834-46.
18. 18 De Weck AL. Cellular allergen stimulation test (CAST) - an overview and critical evaluation of clinical application in allergy diagnosis. Allergologie 1997; 20:487-502.
19. 19 Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Clinical patterns of hypersensitivity to non-steroidal and anti-inflammatory drugs and their pathogenesis. J Allergy Clin Immunol 1977; 60:276-84.
20. 20 Scadding GK, Lund VJ, Jaques LA. A placebo-controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: efficacy in allergic and non-allergic perennial rhinitis. Clin Exp Allergy 1995; 25:737-43.
21. 21 Möller C, Mygind N. Nasal blockage in children with non-infectious rhinitis: consequences and treatment. Allergy 1997; 52 (Suppl. 40):45-51.
22. 22 Okuda Y, Hattori H, Takashima T et al. Basophil histamine release by platelet-activating factor in aspirin-sensitive subjects with asthma. J Allergy Clin Immunol 1990; 86:548-53.
23. 23 Pearson DJ, Suarez-Mendez VJ. Abnormal platelet hydrogen peroxide metabolism in aspirin hypersensitivity. Clin Exp Allergy 1990; 20:157-63.
24. 24 Wolanczyk-Medrala A, Medrala W, Mtolepszy J, Liebhart J, Pietrzak E. CAST-ELISA test in diagnosis of aspirin-induced asthma. J Invest Allergy Clin Immunol 1997; 7:13-7.
25. 25 Szmidt M, Grzelewska-Kzymowska I, Rzniecki J. Tolerance to aspirin in aspirin-sensitive asthmatics. Methods of inducing the tolerance state and its influence on the course of asthma and rhinosinusitis. J Invest Allergol Clin Immunol 1993; 3:156-9.
26. 26 Pleskow W, Stevenson DD, Mathison DA, Simon RA, Schatz M, Zeiger RS. Aspirin-sensitive rhinosinusitis/asthma: spectrum of adverse reactions to aspirin. J Allergy Clin Immunol 1983; 71:574-9.
27. 27 Kawai S. Cyclooxygenase selectivity and the risk of gastro-intestinal complications of various non-steroidal antiinflammatory drugs: a clinical consideration. Inflamm Res 1998; 47:S102-S106.
28. 28 Noreen Y, Ringbom T, Perera P, Danielson H, Bohlin L. Development of a radiochemical cyclooxygenase-1 and -2 in vitro assay for identification of natural products as inhibitors of prostaglandin biosynthesis. J Nat Prod 1998; 61:2-7.
29. 29 Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1993; 90:11693-7.
30. 30 Sladek K, Szczeklik A. Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma. Eur Respir J 1993; 6:391 -9.
31. 31 Sladek K, Dworski R, Soja J et al. Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med 1994; 149:940-6.
32. 32 Fischer AR, Rosenberg MA, Lilly CM et al. Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma. J Allergy Clin Immunol 1994; 94:1046-56.
33. 33 Lane SJ, Lee TH. Mast cell effector mechanisms. J Allergy Clin Immunol 1996; 98:S67-S71.
34. 34 Nasser S, Christie PE, Pfister R et al. Effect of endobronchial aspirin challenge on inflammatory cells in bronchial biopsy samples from aspirin-sensitive asthmatic subjects. Thorax 1996; 51:64-70.
35. 35 Lumry WR, Curd JG, Zeiger RS, Pleskow WW, Stevenson DD. Aspirin-sensitive rhinosinusitis: the clinical syndrome and effects of aspirin administration. J Allergy Clin Immunol 1983; 71:580-7.
36. 36 Barnes PJ. Inhaled glucocorticosteroids for asthma. N Engl J Med 1995; 332:868-75.
37. 37 Akerlund A, Bende M, Intaglietta M, Arfors KE. The effect of oxymetazoline on nasal and mucosal blood flow in the rabbit as measured with laser-Doppler flowmeter. Ann Otol Rhinol Laryngol 1993, 102:123-6.